DeSutter Robert Andrew 4
4 · Sanara MedTech Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Sanara MedTech (SMTI) Director Robert DeSutter Receives Award
What Happened
- Robert DeSutter, a director of Sanara MedTech Inc. (SMTI), received a grant of 5,539 restricted shares on June 4, 2026. The reported price is $0.00 (acquisition value shown as $0 in the filing).
Key Details
- Transaction date: 2026-06-04; Form 4 filed: 2026-06-05.
- Amount: 5,539 shares granted; reported price per share: $0.00; reported acquisition value: $0.
- Vesting: Shares vest on the earlier of the 2027 annual shareholder meeting or June 4, 2027, provided DeSutter continues providing certain services (per footnote referencing the 2024 Omnibus Long-Term Incentive Plan).
- Shares owned after the transaction: not specified in the provided filing information.
- No indication in the filing of a 10b5-1 plan, tax-withholding sale, or a late filing.
Context
- This is a restricted stock award (grant), not a market purchase or sale. Such grants are common for directors as compensation and do not by themselves indicate buying or selling sentiment. The shares will remain subject to vesting conditions until the stated vesting date.
Insider Transaction Report
Form 4
DeSutter Robert Andrew
Director
Transactions
- Award
Common Stock
[F1]2026-06-04+5,539→ 28,740 total
Footnotes (1)
- [F1]Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Signature
/s/ Robert A. DeSutter|2026-06-05